PatientWing positions itself as a patient recruitment and enrollment acceleration platform for clinical research. Its target customers include biopharma sponsors, CROs, research sites, and academic institutions, while it also offers patients disease communities, clinical research education, patient stories, and study information. It is not a typical self-service general-purpose SaaS product, but rather a vertical solution combining a technology platform, recruitment services, and patient engagement operations. Its main focus is solving the challenges of finding, educating, and converting patients for rare disease and serious illness studies.
Its core modules include custom study websites and online pre-screeners that translate study information into patient-friendly content; study branding, naming, logos, and materials designed for patients, sites, and physicians; and multi-channel outreach through social media, patient advocacy organizations, informational resources, and digital advertising. Its patient enrollment team also provides white-glove services such as phone screening, medical record collection, and pre-screening appointment scheduling. The site also emphasizes diverse patient participation and states that it operates in more than 30 countries, making it suitable for studies with cross-regional recruitment needs.
The website does not disclose standard plans, unit pricing, project-based or enrollment-based billing, or whether a free trial is available. Enterprise customers need to get in touch through a form or download case studies to move the conversation forward, so procurement appears to be more customized and project-based. For pharmaceutical companies and CROs, this makes it easier to tailor solutions by indication, country, number of sites, and recruitment targets, but it also reduces budget transparency and upfront comparability.
The main advantages are its focused use case and complete service chain, covering patient education, pre-screening, medical records, and site handoff. Case studies also suggest that it has contributed to study enrollment and helped save recruitment time. The downside is that publicly available information lacks key enterprise software details such as APIs, third-party system integrations, permission-based collaboration, and data security/compliance certifications. Although the service involves medical records and patient communication, there is no clear mention of HIPAA, GDPR, SOC 2, or similar standards, so buyers should prioritize due diligence during procurement.
PatientWing is best suited for overseas clinical research teams, CROs, and research sites in areas such as rare diseases, immunology, gastroenterology, and neurology that need to improve patient enrollment efficiency. Its accessibility from China is unknown, and the site does not disclose Chinese localization, RMB payments, domestic compliance, or a local team. If conducting research in China, it is advisable to also evaluate local CRO recruitment services, hospital research networks, and drug clinical trial registration-related platforms as alternatives or complements.
β This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on patientwing.com official site.
patientwing.com is an United States SaaS Tools provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach patientwing.com directly.